Division of Solid Tumor Oncology

At the Sidney Kimmel Comprehensive Cancer Center at Jefferson Health, we offer a unique opportunity to engage in the care of patients with rare and complex sarcomas. By joining our program, you'll receive invaluable experience and education that will prepare you for a rewarding career in medicine, all while making a real difference in the lives of patients battling these challenging cancers. 

Sarcomas are rare and complex tumors that arise from connective tissue like fat, muscle, bone, and nerves. Although they account for only 1% of adult cancers, there are over 100 different subtypes of soft tissue sarcomas, each with its own unique challenges. Due to their rarity and diversity, sarcoma patients require specialized care, often best provided by expert sarcoma centers following NCCN guidelines.

As a medical student in our Sarcoma Program, you’ll work with a multidisciplinary team—oncologists, surgeons, radiologists, pathologists, and more—who collaborate to develop personalized treatment plans based on factors like tumor location, size, grade, and the patient's unique needs. This team-based approach is critical for achieving the best possible outcomes for sarcoma patients.

Get hands-on experience with cutting-edge treatments and be a part of a program that provides specialized, compassionate care for patients facing these rare and challenging cancers. This is your chance to engage with rare cases, contribute to research, and make a real impact in the lives of patients.

Atrayee Basu Mallick, MD serves as the Enterprise Director of the Bone and Soft Tissue Sarcoma Center and the leader of the multidisciplinary (multi-D) team, Dr. Basu Mallick has dedicated her career to formulate the best treatment plan for each patient. The team works in active collaboration with other physicians and supportive care services through shared decision-making, using the most up-to-date diagnostic technology, and treatment options including clinical trials available at Jefferson. Each patient's journey is unique and she is honored to be a part of it.

How We Make a Difference

The Jefferson Bone Tumor and Soft Tissue Sarcoma Center:

• Is one of the United States’ few complete sarcoma centers – leading to better patient outcomes overall. We have considerable expertise in treating rare, varied and difficult types of soft tissue sarcoma and bone cancers including chondrosarcoma, Ewing’s sarcoma and osteosarcoma.
• Holds biweekly tumor board meetings to discuss complex cases, referred locally and throughout the tri-state area, to develop the best options for management and sequencing of therapy as well as to find relevant clinical trials where applicable. These discussions also facilitate the activation of appropriate clinical trials based on our patient population and referral base.
• Has a designated, experienced multi-D team that meets with patients and their support persons conveniently in a single visit, as well as a designated patient navigator to help ease and coordinate the patient experience. The team frequently supplies second opinions per request.
• Includes experts who specialize in soft tissue and bone sarcoma pathology, orthopedic oncology, surgical oncology, radiation oncology, musculoskeletal radiology, medical oncology, cardiothoracic surgery, otolaryngology, neurosurgery, ophthalmology, plastic surgery, reproductive medicine and musculoskeletal rehabilitation all under the same roof.
  • Combines our NCI designated Sidney Kimmel Comprehensive Cancer Center oncology services with the orthopedic expertise of Rothman Orthopaedics at Jefferson Health.
  • Has a dedicated musculoskeletal radiology team specializing in diagnosis and therapeutic interventions for sarcoma patients.
  • Integrates a dedicated team of anesthesiologists and rehabilitation medicine physicians who have developed protocols specifically for musculoskeletal oncology patients to optimize their experience while undergoing surgery, during rehabilitation, and returning to function with the highest quality of life possible.
  • Has a very active supportive care team including nutritionists, social workers, pain management specialists and physical and occupational therapists.
• Offers patients the most advanced treatment options in the form of clinical trials in various phases. Patients have access to new and developing drugs in the field due to our robust phase 1 clinical trial portfolio.
• Collaborates with translational and basic laboratory scientists on research projects that stem from cases presented in the multi-D clinic. An example of this are efforts to elucidate molecular pathways and identify novel biomarkers and potential therapeutic targets for chondrosarcoma and chordoma.